Bayer wins US priority review of drug against metastatic prostate cancer Reuters May 5, 2022 With this, the German drugmaker seeks to widen the use of the prostate cancer drug from an early disease stage to metastatic cases
Zydus Cadila launches Enzalutamide to treat prostate cancer EP News Bureau May 9, 2020 The therapy priced at nearly two-thirds the cost of the currently available products in the market
